AU2004212179A1 - Antimicrobial agents from Streptococcus mitis and Streptococcus oralis - Google Patents

Antimicrobial agents from Streptococcus mitis and Streptococcus oralis Download PDF

Info

Publication number
AU2004212179A1
AU2004212179A1 AU2004212179A AU2004212179A AU2004212179A1 AU 2004212179 A1 AU2004212179 A1 AU 2004212179A1 AU 2004212179 A AU2004212179 A AU 2004212179A AU 2004212179 A AU2004212179 A AU 2004212179A AU 2004212179 A1 AU2004212179 A1 AU 2004212179A1
Authority
AU
Australia
Prior art keywords
peptide
peptide according
mitis
oralis
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2004212179A
Other languages
English (en)
Inventor
Robin Anthony Howe
Timothy Rutland Walsh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Bristol
Original Assignee
University of Bristol
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0303369A external-priority patent/GB0303369D0/en
Priority claimed from GB0303375A external-priority patent/GB0303375D0/en
Application filed by University of Bristol filed Critical University of Bristol
Publication of AU2004212179A1 publication Critical patent/AU2004212179A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2004212179A 2003-02-14 2004-02-16 Antimicrobial agents from Streptococcus mitis and Streptococcus oralis Abandoned AU2004212179A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0303369.3 2003-02-14
GB0303369A GB0303369D0 (en) 2003-02-14 2003-02-14 Antimicrobial agents
GB0303375A GB0303375D0 (en) 2003-02-14 2003-02-14 Antimicrobial agents
GB0303375.0 2003-02-14
PCT/GB2004/000592 WO2004072093A2 (en) 2003-02-14 2004-02-16 Antimicrobial agents from streptococcus mitis and streptococcus oralis

Publications (1)

Publication Number Publication Date
AU2004212179A1 true AU2004212179A1 (en) 2004-08-26

Family

ID=32870950

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2004212179A Abandoned AU2004212179A1 (en) 2003-02-14 2004-02-16 Antimicrobial agents from Streptococcus mitis and Streptococcus oralis

Country Status (6)

Country Link
US (1) US20060258596A1 (https=)
EP (1) EP1606309A2 (https=)
JP (1) JP2006519217A (https=)
AU (1) AU2004212179A1 (https=)
CA (1) CA2556351A1 (https=)
WO (1) WO2004072093A2 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0703945D0 (en) * 2007-03-01 2007-04-11 Univ Bristol Peptide
US20110262508A1 (en) * 2007-11-07 2011-10-27 Paul Michael Watt Antimicrobial compositions, formulations and uses thereof
US20110256179A1 (en) 2008-11-17 2011-10-20 Essum Ab Pharmaceutical preparation comprising a combination of streptococcus strains and lactobacillus strains
CA2808793C (en) * 2010-08-31 2020-09-22 Centro Superior De Investigacion En Salud Publica (Csisp) Anti-caries compositions and probiotics/prebiotics
US9925257B2 (en) * 2011-09-23 2018-03-27 Forsyth Dental Infirmary For Children Vaccine and therapeutic delivery system
WO2013044059A2 (en) * 2011-09-23 2013-03-28 Forsyth Dental Infirmary For Children A vaccine and therapeutic delivery system
CN102994434A (zh) * 2012-09-13 2013-03-27 安徽希普生物科技有限公司 重组阳离子抗菌肽g13大肠杆菌基因工程菌及其构建方法
FR2999601B1 (fr) * 2012-12-17 2015-01-30 Urgo Lab Methode pour prevenir et/ou traiter les infections, colonisations ou maladies liees a staphylococcus aureus, pseudomonas aeruginosa, streptococcus pyogenes, enterococcus faecium, enterobacter cloacae, proteus mirabilis et/ou bacteroides fragilis
US11174288B2 (en) 2016-12-06 2021-11-16 Northeastern University Heparin-binding cationic peptide self-assembling peptide amphiphiles useful against drug-resistant bacteria
WO2026032976A1 (en) * 2024-08-09 2026-02-12 Universidade Nova De Lisboa Streptococcus preparation for treatment of respiratory tract infection

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5447914A (en) * 1990-06-21 1995-09-05 Emory University Antimicrobial peptides
US5885782A (en) * 1994-09-13 1999-03-23 Nce Pharmaceuticals, Inc. Synthetic antibiotics
US6964760B2 (en) * 1997-06-10 2005-11-15 University Of Florida Research Foundation Antimicrobial polypeptide, nucleic acid, and methods of use
US6218362B1 (en) * 1997-09-08 2001-04-17 Universite Laval Lantibiotic from Streptococcus mutans and uses thereof
SE511648C2 (sv) * 1998-04-17 1999-11-01 Bacterum Ab Streptokockpreparat för behandling av öroninflammation

Also Published As

Publication number Publication date
EP1606309A2 (en) 2005-12-21
JP2006519217A (ja) 2006-08-24
US20060258596A1 (en) 2006-11-16
WO2004072093A3 (en) 2004-10-14
CA2556351A1 (en) 2004-08-26
WO2004072093A2 (en) 2004-08-26

Similar Documents

Publication Publication Date Title
KR102419616B1 (ko) 항균 요법
Ibrahim Classification of antimicrobial peptides bacteriocins, and the nature of some bacteriocins with potential applications in food safety and bio-pharmaceuticals
KR102499670B1 (ko) 라이신 치환을 포함하는 Romo1 유래 항균 펩타이드 및 그 변이체
JP6818349B2 (ja) アシネトバクター溶解素
CA2866520C (en) Antibacterial peptides derived from defensins
US10781236B2 (en) Bacteriocin composition and method
Pepperney et al. Antibacterial peptides: opportunities for the prevention and treatment of dental caries
US20060258596A1 (en) Antimicrobial agents
Leonard et al. Insights into antimicrobial peptides in fighting anthrax: A review
KR101865782B1 (ko) 바실러스 아밀로리퀴파시엔스 k14로부터 단리된 신규 항균 펩타이드 및 그의 용도
CN112778424B (zh) 嵌合肽r7及其应用
Safari et al. Evaluation of the synergistic effect of LL-37 and Oncorhyncin II Recombinant proteins on Staphylococcus aureus under in vitro conditions
KR102511151B1 (ko) 왕지네 유래 펩타이드 스콜로펜드라신-13을 포함하는 항균 조성물
US11096985B2 (en) Antimicrobial peptides, their variants and uses
US20080026999A1 (en) Two-component bacillus lantibiotic and methods for producing and using the same
WO2005019250A1 (en) Staphylococcus antibiotic peptides with a broad spectrum of action
US7985837B2 (en) Two component Bacillus lantibiotic and methods for producing and using the same
WO2025240841A1 (en) Antimicrobial therapy
HK1237648B (en) Acinetobacter lysins
HK1237648A1 (en) Acinetobacter lysins

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application